# TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection

> **NCT02588755** · NA · UNKNOWN · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Intrahepatic Cholangiocarcinoma

## Interventions

- **PROCEDURE:** TACE+Tegafur
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT02588755
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02588755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02588755, "TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02588755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*